Creative Medical Technology Holdings, Inc. Proceeds from (Repayments of) Related Party Debt
Creative Medical Technology Holdings, Inc. (CELZ) reported Proceeds from (Repayments of) Related Party Debt of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2021-03-17
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for the quarter ending 2019-12-31 was $100.00K.
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for the quarter ending 2016-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for the quarter ending 2015-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Creative Medical Technology Holdings, Inc. proceeds from (repayments of) related party debt for fiscal 2019 was $50.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $0.00 10-K · filed 2021-03-17 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | |||
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $50.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$50.00K 10-Q · filed 2020-11-13 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | -$3.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$3.00K 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | -$3.00K 10-Q · filed 2016-05-13 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | |||
| 2013-09-30 | -$8.32K 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |